Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 StudyNewswise (press release)Newswise — Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with recurrent brain cancer – h… Continue reading
MedCity NewsJ&J puts the brakes on immunotherapy combination studiesMedCity NewsThe maker of a drug approved to treat the blood cancer multiple myeloma has stopped a clinical trial combining it with an immunotherapy agent in lung cancer and stopped… Continue reading
Nature.comStem-cell tests must show successNature.comAs we report in a News story this week, Japan is set to push ahead with a promising treatment for heart disease that relies on stem cells. It could soon be made available under a fast-track approval … Continue reading
Nature.comStem-cell tests must show successNature.comAs we report in a News story this week, Japan is set to push ahead with a promising treatment for heart disease that relies on stem cells. It could soon be made available under a fast-track approval … Continue reading
Singularity Hub |
Microbes in Space: Bioengineered Bugs Could Help Colonize New Planets
Singularity Hub But the emerging field of synthetic biology holds the promise of greatly expanding the things microbes can do for us. Advances in gene editing technology are allowing scientist to re–engineer microbes’ genomes to carry out entirely novel functions like … |
Nature.com |
‘Reprogrammed’ stem cells approved to mend human hearts for the first time
Nature.com Scientists in Japan now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique. The study is only the second clinical application of induced pluripotent stem (iPS) cells. These are created … |